The present paper studies the way intellectual property rights may encourage sustainable medical tourism, meaning the advantages that a patent, traditional knowledge, a trademark, or other IP right may offer to a hospital in order to attract foreign patients. The analysis is done trough the Institute of Gerontology and Geriatrics "Ana Aslan" case study, seen not from a medical point of view but from the perspective of the intellectual property importance for the development of medical tourism. The Institute of Gerontology and Geriatrics "Ana Aslan" was founded in 1952 and become an international renowned center in the study and the diminishing of old age effects. Many celebrities (artist and state presidents) came to receive treatment here, even though Romania had, at that time, a communist regime.
Introduction
Intellectual property (IP) rights represent an important aspect of the human kind evolution, an important tool for economical development and a form of soft power in international relations. Certainly intellectual property represents an advantage for the company which develops such rights. In the private sector the practice to develop new patents or trademarks is worldwide spread, fact proved by the high number of international registrations in this field, originating in countries around the world contracting parties to the international system of trademark or patent registration. The high value of trademarks expressed in brands is another indicator of the importance of intellectual property in the economic sector.
Sometimes the aspects of intellectual property are more valuable than a company's material assets. For example Naomi Klein (2006) was emphasizing that sometimes companies are sold for a large amount of money because of their brand: she is using the example of Kraft Company bought by Philip Morris in the '80's for 12.6 billion, dollars six times the company's value on paper. Inventions can boost the value of a company in the same manner. This is obvious in the pharmaceutical industry where new patented substances increase the value of a company such as the Viagra patent and trademark. The product Viagra is a big hit for Pfizer and a highly counterfeited product.
The same principles can be applied to medical tourism. Medical tourism developed lately due to the new means of communication which brought the information at a "click" distance from the interested patient and due to the fastest means of transport, which facilitate the access to other countries. This can open a new chapter in international relations, and regulations, but also in the hospital development.
But the main question is what makes a patient choose a hospital form a different country. Intellectual property rights might just be one of the reasons. Either we talk about a patent of a new surgical procedure performed only in one hospital or a few, or the patent of a valve or prosthesis of any kind that can be found in just one country these may just cover the needs of that patient. But this may prove insufficient, because patients must find out about these hospitals. So trademarks come into place.
The trademarks embodied in a brand can make the difference between two or more hospitals. Consumers, when faced with the decision of choosing between similar products tend to choose brand products because they are more familiarized with them. The same may be the case of hospitals; even if in some countries (Romania for example) they are mainly public entities. If we talk about national brands, regional brands and company brands, than, maybe even a public entity could develop a brand.
In order to see the impact of IP elements over medical tourism we choose to present a Romanian hospital tourism case, namely the Institute of Gerontology and Geriatrics named after a famous Romanian researcher: Ana Aslan. This case study may give some directions for state policies or hospitals policies in the field of encouraging medical tourism. The development of research center, with patented results, may give in certain situations a considerable advantage to a hospital. Also, the new situation requests the need to develop hospital brands, which can give them an advantage over other competitors.
2.0
Institute of Gerontology and Geriatrics "Ana Aslan"
Generally, in Romania, hospitals are public entities more than 80% are public hospitals and the rest are either foundations or private companies. The management is done through a management team appointed by the ministry for the big hospitals and for the little ones by local authorities. The same is the case of the Institute of Gerontology and Geriatrics Ana Aslan. The story of the institute goes back a while, during the communist regime, when the researcher and physician Ana Aslan developed and patented a new treatment.
The history of the institute is presented mainly on "Farmec" Company and Institute of Gerontology and Geriatrics "Ana Aslan" web pages and also by Neica and Aldulea (2009) . The starting point of the story is the year 1952, when the first institute of geriatrics in the world was founded in Romania under the leadership of Ana Aslan (Farmec Company official website, Neica and Aldulea (2009) , and Institute of Gerontology and Geriatrics "Ana Aslan" webpage ). Since then, the institute conducted researches on the effects of old age and how they can be diminished and on the treatment of patients suffering from the effects of old age. The structure of the institute combines research with the practical treatment of patients. This fact is proven by the three direction of the institute: clinical, experimental and social research. An important statement for the innovative character and quality provided by the institute is the fact that the WHO (Kiev, 1963) recommended the structure of this institute as a model for similar institutions (Institute of Gerontology and Geriatrics "Ana Aslan" webpage). During the communist years the institute had national and foreign patients; it has developed innovative treatments for the effects of old age, and contributed to the international researches in the fields of gerontology and geriatrics (Institute of Gerontology and Geriatrics "Ana Aslan" webpage).
The fame of the institute is related to the research carried out here by the doctor and researcher PhD Ana Aslan, prof. C. I. Parhon and the pharmacist Elena Polovrageanu. In a decade starting from 1946 to 1956 doctor Ana Aslan and other doctors of the institute started an experimental research regarding a medicine meant to delay aging. The research regarding at first the effects of Novocain and then in 1956 the Gerovital H3 product was presented at a congress of Gerontology in Basel (Farmec Company official website, Neica and Aldulea (2009) , and Institute of Gerontology and Geriatrics "Ana Aslan" webpage).
Because of the skepticism of the international researchers, Ana Aslan initiated a research program in order to confirm her theory that included patients all over Romania. The results confirmed her theory regarding the capacity of the product to delay the effects of old age as presented by Neica and Aldulea (2009) . According to the institute of Gerontology and Geriatrics website, the treatment "by procaine on third-age patients are mainly the reduction of depression and anxiety, improvement of the will to live, growth of physical and intellectual capability (especially memory, auditory, visual and olfactive apparata, Nang Yan Business Journal -2.1 -2013 (2009)). The number and names of the patients vary from an information source to another, and an official list of the celebrities treated here was not disclosed by the institute, fact understandable if we take into account doctor's obligation of confidentiality regarding patient, and maybe other confidentiality agreements not made public, but possible, due to the fact that state presidents were patients of the institute. We have contacted the institute in order to obtain some statistical data regarding foreign patient but we were informed that such data are not available at the moment.
So we have no statistical indicator of the phenomenon of medical tourism related to the activity of the institute. But instead factual indicators exist. Firstly a new center of treatment was built in 1974 at Otopeni, locality near Bucharest, important because there is located the biggest Romanian international airport. Moreover, other subordinated institutes were created in different locations that combined natural factors with treatments in the mountains, balneal or seaside locations. Farmec Company reports that it was a profit of 17.000.000 $ annually (from the products and treatments of Ana Aslan), the entire amount entered in the state's budget.
After the fall of the communist regime the good will of the institute faded due to a lack of interest and underfunding of the institute, fact underlined in an investigation made by Paula Herlo (2009) . Also, the research and treatments of Ana Aslan were later criticized in many scientific papers. This lead to the prohibition of procaine use in the USA by United States Food and Drug Administration (FDA) for cosmetic or other treatments. In 2009 a serious investment was made and the institute and its centers were rehabilitated in 2011. The institute management states in a recent press release: "all 580 beds are occupied, and that the waiting list is 4-6 months". Also the officials mention some foreign petition for treatment in the institute centers (Aurelia Alexa (2011)). These official statements indicate that the intention is to bring back the institute to the fame it had before. The official website of the institute is available in Romanian English and Japanese. This fact indicates that international patients are expected and that a special focus is given to Japan as a potential market for medical tourism.
Another problem that appeared after the fall of the communist regime was the rightful use of the patents and trademarks of Ana Aslan. The right to produce pills and injections remained to Sicomed SA, company bought by the Zentiva Company. Ziarul Financiar (2012) reported that Sanofi Aventis has around 80% of Zentiva, which means that the right to use the trademark for this products passes to Sanofi Aventis.
The right to use the trademark Gerovital for cosmetics remains to Farmec Company and represent according to Ileana Ilie (2011) , around 60% of the company's turnover. Bizz magazine (2011) published top 50 Romanian brands where Gerovital was placed in the fourth place while the brand of the company that produces it was on the 16 th place. So the product brand is stronger than the producer's brand. Also in 2012 in an interview with Cristina Rosca (2012) the general director state the company's intention to extent its market in Ukraine Poland and Hungary, because at the present the company exports manly in America and Asia especially Japan. These informations give the dimension of the importance of the patents and trademarks developed in the Institute of Gerontology and Geriatrics Ana Aslan.
An important aspect that needs to be mentioned is that Farmec had to fight Mirage Bucharest, later named Gerovital Cosmetics, for the exclusive right to use the Gerovital Trademark. The litigation was brought before the Appeal Court of Bucharest Award no. 5419 of July 3th 2007, and Romanian High Court of Justice where Farmec lost the appeals. In the end after a long litigation process before the Romanian courts, Farmec Company obtained the sole use of the Gerovital trademark, after paying 1.2 million euro to Gerovital Cosmetics (Farmec webpage, Ziua de Cluj webpage).
IP Importance for Medical Tourism
From the case study presented above it is obvious that patents and trademarks are an important asset for a hospital. In the end all the fame of the institute was related to the discoveries made by Ana Aslan and the pharmacist Elena Polovrageanu, and the treatments administered in the Institute of Gerontology and Geriatrics.
From the point of view of trademarks it is obvious that the institute name was not registered as a trademark. This is explainable because of the communist regime in Romania that registered trademarks but especially those that were exported. Due to a lack of a free market and as a consequence a lack of competition, the institute was not protected as a trademark. The trademarks Gerovital was protected by "Farmec", the company that received the right to produce and sell cosmetics that contained the innovations made in the Institute. In 1966, the Gerovital trademark was registered in 27 countries and the owner was Farmec Company of Cluj Napoca, for the class 03 "Cosmetic products containing novocaine" (Registration no. 319015A -Gerovital H3, World Intellectual Property Organization (WIPO) database of trademarks).
Because of this lack of protection the goodwill of the institute and the treatments performed here, were lost in the international public opinion during the transition from a communist regime to a democratic one. Another problem is the public management of the institute that was indifferent to the potential that the institute has.
Nevertheless, hospitals can be registered as trademarks and can be promoted at international level. Over 400 years ago Francisc Bacon said that information is power. Today Nye and Keohane (2009) point out that because of the internet the access to information is no longer a problem but the selection of information offers the key to power. In this context trademarks can make the difference between information and no information. This is another reason for the need of hospitals trademarks. Also the presence of hospitals on Internet facilitates the patients access to information. So in this case the two main features of a trademark described by Kotler (1997) : "feature of a certain standard of quality and the protection of the trademark's distinctive character", is completed by a third, the access to treatment, which is a basic need of the individuals that sometimes makes the difference between life and death.
According to the international classification of trademarks hospitals or care centers are service marks. This may pose some problems in the practice to develop brands due to the special nature of customer satisfaction they can offer. Olins W. (2006) emphasizes the subjective nature of a service brand, subjectivity due to human interaction. In a study, Chao-Chan Wu (2011) analyzing the impact of hospital brands on service quality, patients satisfaction and loyalty, emphasizes the role of a brand for a hospital, concluding after a case study focusing on large size hospitals located in Taiwan that brands are important for patients loyalty and the impression of service quality the patient has. This study demonstrates as well as our case study that registering a trademark and developing it into a brand can bring many advantages for a hospital in the quest for acquiring a part of the international market of medical tourism.
Many things can influence the good will of a hospital brand. The case study of Ana Aslan shows that a new medical specialty can influence the way a hospital is regarded by possible patients. Also the possibility to treat ones disease in only one or a few centers in the world creates the premises for medical tourism. But founding a new specialty is not enough for reaching a certain level of fame needed for medical tourism. Certain studies conducted, patient care, new treatments, new patents or international scientific recognition contribute to the required good will of a high value medical tourism facility.
A certain level of quality can also be a reason why patients choose to treat their diseases in another hospital. A high level of quality, standards of patient care good medical specialists can all influence the image of a hospital.
Also certain famous doctors, highly regarded specialists in their field can be a reason for medical tourism, because patients can sometime choose to be treated by certain doctors. This can open a new chapter in human resources recruiting because hospitals may want to be associated with famous doctors that may bring a certain level of good will.
Hospitals should be interested in developing patents in the form of new techniques in surgery, treatments, and other patentable medical results. In the presented case Ana Aslan was also a researcher and studied the action of procaine over elderly patients. But not only new substances have important contributions for hospital tourism. New procedures in treating certain diseases, diagnosis tools or other medical inventions can have the same impact too. This is why they can be patented according to the Strasbourg Agreement Concerning the International Patent Classification, 1971, class 61 "medical or veterinary science; hygiene". In this case we can state that research in a hospital can create an advantage for services it offers to patients.
Another aspect of IP that must be mentioned, even if in the case study it does not appear, is the traditional knowledge applied in hospital tourism. Sometimes traditional remedies, the use of local plants/methods can offer treatment for some medical conditions. For example traditional Chinese and Indian medicines have different way of treating diseases than western conventional medicines. Developing health care institutions using this kind of treatments can be a base for developing hospital tourism in some countries.
International Relations and Medical Tourism
From the Institute of Gerontology and Geriatrics Ana Aslan case study another important fact was reveled and is related to political aspects of international relations. At the time when the Institute was frequented by foreign patients Romania was a communist country. As a communist country the occident was not seen as a good standard and most of the information coming from the capitalist countries was censored. Films, music, books all were censored by the communist, western brands were not imported. Political relations were tensioned, in the end we are talking about the cold war.
In this context democratic political figures, artist and other famous people came into Romania to receive treatment. Statesman from conflicting states at the time received treatment here: Nikita Hruşciov, Tito, Winston Churchill, Charles de Gaulle, J. F. Kennedy. This fact can be explainable only trough one thing: when talking about hospital tourism and patients needs the political aspects become less relevant, compared to a basic human need, the need of health. The idea of health is more related to the concept of human security and the duty of the state to ensure the means to treat its citizens. Also, another important conclusion is that the institute associate itself to elites, personalities form different fields and not as much to general public.
Also famous hospitals can concur to the development of national brands because the good will of products and services produced or offered in one country are directly reflected in the way that state is perceived by the international community. Ana Aslan's Institute brought an important sum of money to the Romanian state due to the products produced after her formula and services offered in the institute. Also the fact that many celebrities came to Romania to receive treatments offered an important contribution to the international image of a communist country.
Another aspect related to international relations and medical tourism is the regulations that need to be implemented in this field. Niechajev I. and Frame J. (2012) present cases in which medical tourism was detrimental to the patient's health, resulting even in death. Every state implements a different level of medical quality some a higher one others a lower one. Sometime the publicity made to a hospital trough adds or internet pages do not reflect reality. So international regulations must be adopted and implemented in order to protect patients that choose a hospital from another country. In this case WHO can implement standards and alerts for certain medical centers that do not practice quality medical services.
Conclusions
Intellectual property is an important aspect for medical tourism from the perspective of attracting patients from all over the world, but also for the patient's choice for medical treatment. From this point of view, IP offers the same sustainable advantage to the hospital as it offers to companies in other sectors.
